Order Article Reprints
Journal: Cancers, 2024
Volume: 16
Number: 2287
Article:
Reasonability of Frequent Laboratory Analyses during Therapy with Nivolumab and Nivolumab+Ipilimumab in Patients with Advanced or Metastatic Renal Cell Carcinoma during the Phase 2 Clinical Trial TITAN-RCC
Authors:
by
Klara Franke, Susan Foller, Michele Estephania Rosero Moreno, Nalyan Ali, Lutz Leistritz, Katharina Leucht and Marc-Oliver Grimm
Link:
https://www.mdpi.com/2072-6694/16/12/2287
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.